| Primary |
| Prophylaxis Against Transplant Rejection |
22.2% |
| Immunosuppressant Drug Therapy |
14.3% |
| Renal Transplant |
12.7% |
| Prophylaxis |
7.9% |
| Transplant Rejection |
7.9% |
| Product Used For Unknown Indication |
6.3% |
| Liver Transplant |
5.6% |
| Immunosuppression |
3.2% |
| Intestine Transplant Rejection |
3.2% |
| Premedication |
3.2% |
| Renal And Pancreas Transplant Rejection |
2.4% |
| Cytomegalovirus Infection |
1.6% |
| Drug Use For Unknown Indication |
1.6% |
| Epstein-barr Virus Infection |
1.6% |
| Ill-defined Disorder |
1.6% |
| Transplant |
1.6% |
| Autoimmune Disorder |
0.8% |
| Kidney Transplant Rejection |
0.8% |
| Liver Transplant Rejection |
0.8% |
| Pancreas Transplant Rejection |
0.8% |
|
| Bacterial Test |
17.4% |
| Epstein-barr Virus Associated Lymphoproliferative Disorder |
17.4% |
| Cytomegalovirus Test Positive |
8.7% |
| Liver Transplant Rejection |
8.7% |
| Heart Transplant Rejection |
6.5% |
| Meningitis Aseptic |
4.3% |
| Pyrexia |
4.3% |
| Ventricular Tachycardia |
4.3% |
| Wheezing |
4.3% |
| Bacteraemia |
2.2% |
| Blood Creatinine Increased |
2.2% |
| Cytomegalovirus Infection |
2.2% |
| False Positive Investigation Result |
2.2% |
| Hyperparathyroidism |
2.2% |
| Influenza Like Illness |
2.2% |
| Liver Graft Loss |
2.2% |
| Lymphoproliferative Disorder |
2.2% |
| Multi-organ Failure |
2.2% |
| Myocardial Infarction |
2.2% |
| Neutropenia |
2.2% |
|
| Secondary |
| Immunosuppression |
19.2% |
| Bone Marrow Conditioning Regimen |
18.4% |
| Prophylaxis Against Transplant Rejection |
12.5% |
| Renal Transplant |
7.1% |
| Stem Cell Transplant |
6.3% |
| Acute Lymphocytic Leukaemia |
5.1% |
| Immunosuppressant Drug Therapy |
4.7% |
| Kidney Transplant Rejection |
3.5% |
| Acute Lymphocytic Leukaemia Recurrent |
3.1% |
| Thrombosis Prophylaxis |
2.7% |
| Infection Prophylaxis |
2.4% |
| Antiviral Prophylaxis |
2.0% |
| Prophylaxis |
2.0% |
| Prophylaxis Against Graft Versus Host Disease |
2.0% |
| Bone Marrow Transplant |
1.6% |
| Drug Use For Unknown Indication |
1.6% |
| Epstein-barr Virus Infection |
1.6% |
| Liver Transplant Rejection |
1.6% |
| Lymphocytic Leukaemia |
1.6% |
| Antibiotic Therapy |
1.2% |
|
| Stomatitis |
12.8% |
| Transplant Rejection |
10.6% |
| Meningitis Aseptic |
8.5% |
| Progressive Multifocal Leukoencephalopathy |
8.5% |
| Renal Impairment |
8.5% |
| Respiratory Failure |
6.4% |
| Chronic Myeloid Leukaemia |
4.3% |
| Death |
4.3% |
| Graft Versus Host Disease |
4.3% |
| Myelopathy |
4.3% |
| Thrombotic Microangiopathy |
4.3% |
| Thyroid Cancer |
4.3% |
| Vasculitis |
4.3% |
| Anaemia |
2.1% |
| Ascites |
2.1% |
| Epstein-barr Virus Associated Lymphoproliferative Disorder |
2.1% |
| Heart Transplant Rejection |
2.1% |
| Immune Reconstitution Syndrome |
2.1% |
| Intestine Transplant Rejection |
2.1% |
| Kidney Transplant Rejection |
2.1% |
|
| Concomitant |
| Renal Transplant |
27.0% |
| Prophylaxis Against Transplant Rejection |
11.3% |
| Prophylaxis Against Graft Versus Host Disease |
9.5% |
| Immunosuppressant Drug Therapy |
8.6% |
| Prophylaxis |
6.8% |
| Acute Lymphocytic Leukaemia |
5.4% |
| Immunosuppression |
5.4% |
| Graft Versus Host Disease |
4.1% |
| Heart Transplant |
4.1% |
| Bone Marrow Transplant |
2.7% |
| Kidney Transplant Rejection |
2.7% |
| Transplant Rejection |
2.3% |
| Gastrointestinal Haemorrhage |
1.8% |
| Antiviral Prophylaxis |
1.4% |
| Drug Use For Unknown Indication |
1.4% |
| Procedural Pain |
1.4% |
| Product Used For Unknown Indication |
1.4% |
| Wound Infection |
1.4% |
| Antifungal Prophylaxis |
0.9% |
| Enterococcal Infection |
0.9% |
|
| Mucosal Inflammation |
9.8% |
| Transplant Rejection |
9.8% |
| Drug Dispensing Error |
7.3% |
| Viral Infection |
7.3% |
| Acute Graft Versus Host Disease |
4.9% |
| Acute Lymphocytic Leukaemia Recurrent |
4.9% |
| Epstein-barr Virus Associated Lymphoproliferative Disorder |
4.9% |
| Kidney Transplant Rejection |
4.9% |
| Osteonecrosis |
4.9% |
| Pneumonia Cytomegaloviral |
4.9% |
| Renal Cancer |
4.9% |
| Soft Tissue Inflammation |
4.9% |
| Spinal Compression Fracture |
4.9% |
| Urinary Retention |
4.9% |
| Vomiting |
4.9% |
| Acute Myeloid Leukaemia Recurrent |
2.4% |
| Blood Glucose Decreased |
2.4% |
| Chronic Graft Versus Host Disease |
2.4% |
| Culture Urine Positive |
2.4% |
| Diarrhoea |
2.4% |
|
